These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Enzyme replacement therapy: a new treatment concept in Gaucher disease]. Beck M; Mengel E; Barone R Wien Klin Wochenschr; 1997 Feb; 109(3):81-5. PubMed ID: 9139464 [TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease. Zimran A; Loveday K; Fratazzi C; Elstein D Blood Cells Mol Dis; 2007; 39(1):115-8. PubMed ID: 17391996 [TBL] [Abstract][Full Text] [Related]
14. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606 [TBL] [Abstract][Full Text] [Related]
15. Gaucher's disease: a review for the internist and hepatologist. Niederau C; Häussinger D Hepatogastroenterology; 2000; 47(34):984-97. PubMed ID: 11020862 [TBL] [Abstract][Full Text] [Related]
17. First long-term results of imiglucerase therapy of type 1 Gaucher disease. Niederau C; vom Dahl S; Häussinger D Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964 [TBL] [Abstract][Full Text] [Related]